ArticleAmerican journal of clinical pathology2018
Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions.
Article in American journal of clinical pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- How defensive medicine is defined in European medical literature: a systematic review.BMJ open · 2022Pooled it
- [IGeL in dermatopathology-structural limitations and legal risks].Dermatologie (Heidelberg, Germany) · 2026Article
- Thin Equivocal Melanocytic Lesions and Melanoma in Situ: The Monitoring Versus Excision Dilemma in Daily Clinical Practice.Dermatology practical & conceptual · 2026Article
- Defensive medicine in dermatological practice - Dermatopathology as a mirror of structural challenges.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026Review
- Decision Fatigue in Dermatopathology: Cognitive Load and Diagnostic Vulnerability.Journal of cutaneous pathology · 2025Article
- Is Dermoscopy Destroying Clinical Dermatology?Dermatology practical & conceptual · 2025Article
- Excision margins and prognosis in cutaneous melanoma: retrospective population-based cohort study.BJS open · 2025Article
- Article
- [Immunohistochemical examinations in malignant melanoma : Fundamentals and special aspects].Dermatologie (Heidelberg, Germany) · 2024Article
- Quality measures in primary care skin cancer management: a qualitative study of the views of key informants.BMJ open · 2024Article
- A clinical impact study of dermatologists' use of diagnostic gene expression profile testing to guide patient management.Melanoma management · 2024Article
- Not Your Mother's Melanoma: Causes and Effects of Early Melanoma Diagnosis.Dermatopathology (Basel, Switzerland) · 2022Review
- Use of modifying phrases in surgical pathology reports: is there a different understanding between pathologists and treating physicians?Virchows Archiv : an international journal of pathology · 2022Article
- Assessment of a Diagnostic Classification System for Management of Lesions to Exclude Melanoma.JAMA network open · 2021Article
- The utility of digital pathology in improving the diagnostic skills of pathology trainees in commonly encountered pigmented cutaneous lesions during the COVID-19 pandemic: A single academic institution experience.Annals of diagnostic pathology · 2021Article
- Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects.Frontiers in medicine · 2021Review
- Malpractice and Patient Safety Concerns.American journal of clinical pathology · 2020Article
- Factors associated with use of immunohistochemical markers in the histopathological diagnosis of cutaneous melanocytic lesions.Journal of cutaneous pathology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesThe impact of malpractice concerns on pathologists' use of defensive medicine and interpretations of melanocytic skin lesions (MSLs) is unknown.
methodsA total of 207 pathologists interpreting MSLs responded to a survey about past involvement in malpractice litigation, influence of malpractice concerns on diagnosis, and use of assurance behaviors (defensive medicine) to alleviate malpractice concerns. Assurance behaviors included requesting second opinions, additional slides, additional sampling, and ordering specialized tests.
resultsOf the pathologists, 27.5% reported that malpractice concerns influenced them toward a more severe MSL diagnosis. Nearly all (95.2%) pathologists reported practicing at least one assurance behavior due to malpractice concerns, and this practice was associated with being influenced toward a more severe MSL diagnosis (odds ratio, 2.72; 95% confidence interval, 1.41-5.26).
conclusionsOne of four US skin pathologists upgrade MSL diagnosis due to malpractice concerns, and nearly all practice assurance behaviors. Assurance behaviors are associated with rendering a more severe MSL diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.